Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.
Federal officials say the US Food and Drug Administration (FDA) is reviewing reports of possible deaths in adults and children following COVID-19 vaccination.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback